The perfect trio to decrease mortality in pancreatic cancers: Molecular marker screening tests with biosensors in precancerous lesions

The mortality rates of pancreatic cancer (PC) are very high. The methods recommended in the studies conducted to date have been able to reduce mortality very little. This study aimed to review studies on this subject and to identify the most appropriate methods to decrease mortality in PCs. Therefor...

Full description

Saved in:
Bibliographic Details
Published inAsian Journal of Medical Sciences Vol. 14; no. 12; pp. 267 - 277
Main Authors Hasan Zafer Acar, Nazmi Özer
Format Journal Article
LanguageEnglish
Published 01.12.2023
Online AccessGet full text
ISSN2467-9100
2091-0576
DOI10.71152/ajms.v14i12.3396

Cover

More Information
Summary:The mortality rates of pancreatic cancer (PC) are very high. The methods recommended in the studies conducted to date have been able to reduce mortality very little. This study aimed to review studies on this subject and to identify the most appropriate methods to decrease mortality in PCs. Therefore, research articles and reviews on this subject were analyzed intensely, and the findings were summarized. According to the results obtained in our study, to decrease mortality in pancreatic ductal adenocarcinomas, early diagnostic screening should be performed primarily with molecular markers and biosensors effective in precancerous lesions in risk groups. However, studies on such screening worldwide have not yet been conducted. Therefore, further research is needed to arrive at more precise conclusions.
ISSN:2467-9100
2091-0576
DOI:10.71152/ajms.v14i12.3396